- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Colloids (Blood Plasma) market will register a -2.6% CAGR in terms of revenue, the global market size will reach $ 377.5 million by 2025, from $ 419.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Colloids (Blood Plasma) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Colloids (Blood Plasma) market by type, application, key manufacturers and key regions and countries.
This study considers the Colloids (Blood Plasma) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Behring
Boya Rongsheng
Baxter
Octapharma
Kedrion
Grifols
Hualan Bio
Shanghai Raas
Rongsheng Pharmaceutical
CTBB
CR Double-Crane
Shandong Qidu Pharmaceutical
Kelun Group
B. Braun Medical
Axa parenterals
HOSPIRA
Minsheng Pharma
Fresenius Kabi(China)
Fresenius Kabi
Shandong Hualu Pharmaceutical
Kanglepharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Colloids (Blood Plasma) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Colloids (Blood Plasma) market by identifying its various subsegments.
Focuses on the key global Colloids (Blood Plasma) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Colloids (Blood Plasma) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Colloids (Blood Plasma) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Colloids (Blood Plasma) Consumption 2015-2025
2.1.2 Colloids (Blood Plasma) Consumption CAGR by Region
2.2 Colloids (Blood Plasma) Segment by Type
2.2.1 Natural Type Colloids (Blood Plasma)
2.2.2 Synthetic Type Colloids (Blood Plasma)
2.3 Colloids (Blood Plasma) Consumption by Type
2.3.1 Global Colloids (Blood Plasma) Consumption Market Share by Type (2015-2020)
2.3.2 Global Colloids (Blood Plasma) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Colloids (Blood Plasma) Sale Price by Type (2015-2020)
2.4 Colloids (Blood Plasma) Segment by Application
2.4.1 Extensive Burns
2.4.2 Massive Blood or Plasma Loss
2.4.3 Hypovolemic Shock
2.4.4 Others
2.5 Colloids (Blood Plasma) Consumption by Application
2.5.1 Global Colloids (Blood Plasma) Consumption Market Share by Type (2015-2020)
2.5.2 Global Colloids (Blood Plasma) Value and Market Share by Type (2015-2020)
2.5.3 Global Colloids (Blood Plasma) Sale Price by Type (2015-2020)
3 Global Colloids (Blood Plasma) by Company
3.1 Global Colloids (Blood Plasma) Sales Market Share by Company
3.1.1 Global Colloids (Blood Plasma) Sales by Company (2018-2020)
3.1.2 Global Colloids (Blood Plasma) Sales Market Share by Company (2018-2020)
3.2 Global Colloids (Blood Plasma) Revenue Market Share by Company
3.2.1 Global Colloids (Blood Plasma) Revenue by Company (2018-2020)
3.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Company (2018-2020)
3.3 Global Colloids (Blood Plasma) Sale Price by Company
3.4 Global Colloids (Blood Plasma) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Colloids (Blood Plasma) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Colloids (Blood Plasma) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Colloids (Blood Plasma) by Regions
4.1 Colloids (Blood Plasma) by Regions
4.2 Americas Colloids (Blood Plasma) Consumption Growth
4.3 APAC Colloids (Blood Plasma) Consumption Growth
4.4 Europe Colloids (Blood Plasma) Consumption Growth
4.5 Middle East & Africa Colloids (Blood Plasma) Consumption Growth
5 Americas
5.1 Americas Colloids (Blood Plasma) Consumption by Countries
5.1.1 Americas Colloids (Blood Plasma) Consumption by Countries (2015-2020)
5.1.2 Americas Colloids (Blood Plasma) Value by Countries (2015-2020)
5.2 Americas Colloids (Blood Plasma) Consumption by Type
5.3 Americas Colloids (Blood Plasma) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Colloids (Blood Plasma) Consumption by Regions
6.1.1 APAC Colloids (Blood Plasma) Consumption by Regions (2015-2020)
6.1.2 APAC Colloids (Blood Plasma) Value by Regions (2015-2020)
6.2 APAC Colloids (Blood Plasma) Consumption by Type
6.3 APAC Colloids (Blood Plasma) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Colloids (Blood Plasma) by Countries
7.1.1 Europe Colloids (Blood Plasma) Consumption by Countries (2015-2020)
7.1.2 Europe Colloids (Blood Plasma) Value by Countries (2015-2020)
7.2 Europe Colloids (Blood Plasma) Consumption by Type
7.3 Europe Colloids (Blood Plasma) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Colloids (Blood Plasma) by Countries
8.1.1 Middle East & Africa Colloids (Blood Plasma) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Colloids (Blood Plasma) Value by Countries (2015-2020)
8.2 Middle East & Africa Colloids (Blood Plasma) Consumption by Type
8.3 Middle East & Africa Colloids (Blood Plasma) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Colloids (Blood Plasma) Distributors
10.3 Colloids (Blood Plasma) Customer
11 Global Colloids (Blood Plasma) Market Forecast
11.1 Global Colloids (Blood Plasma) Consumption Forecast (2021-2025)
11.2 Global Colloids (Blood Plasma) Forecast by Regions
11.2.1 Global Colloids (Blood Plasma) Forecast by Regions (2021-2025)
11.2.2 Global Colloids (Blood Plasma) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Colloids (Blood Plasma) Forecast by Type
11.8 Global Colloids (Blood Plasma) Forecast by Application
12 Key Players Analysis
12.1 CSL Behring
12.1.1 Company Information
12.1.2 Colloids (Blood Plasma) Product Offered
12.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Behring Latest Developments
12.2 Boya Rongsheng
12.2.1 Company Information
12.2.2 Colloids (Blood Plasma) Product Offered
12.2.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Boya Rongsheng Latest Developments
12.3 Baxter
12.3.1 Company Information
12.3.2 Colloids (Blood Plasma) Product Offered
12.3.3 Baxter Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Baxter Latest Developments
12.4 Octapharma
12.4.1 Company Information
12.4.2 Colloids (Blood Plasma) Product Offered
12.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Kedrion
12.5.1 Company Information
12.5.2 Colloids (Blood Plasma) Product Offered
12.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Kedrion Latest Developments
12.6 Grifols
12.6.1 Company Information
12.6.2 Colloids (Blood Plasma) Product Offered
12.6.3 Grifols Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Grifols Latest Developments
12.7 Hualan Bio
12.7.1 Company Information
12.7.2 Colloids (Blood Plasma) Product Offered
12.7.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Hualan Bio Latest Developments
12.8 Shanghai Raas
12.8.1 Company Information
12.8.2 Colloids (Blood Plasma) Product Offered
12.8.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Shanghai Raas Latest Developments
12.9 Rongsheng Pharmaceutical
12.9.1 Company Information
12.9.2 Colloids (Blood Plasma) Product Offered
12.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Rongsheng Pharmaceutical Latest Developments
12.10 CTBB
12.10.1 Company Information
12.10.2 Colloids (Blood Plasma) Product Offered
12.10.3 CTBB Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 CTBB Latest Developments
12.11 CR Double-Crane
12.11.1 Company Information
12.11.2 Colloids (Blood Plasma) Product Offered
12.11.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 CR Double-Crane Latest Developments
12.12 Shandong Qidu Pharmaceutical
12.12.1 Company Information
12.12.2 Colloids (Blood Plasma) Product Offered
12.12.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Shandong Qidu Pharmaceutical Latest Developments
12.13 Kelun Group
12.13.1 Company Information
12.13.2 Colloids (Blood Plasma) Product Offered
12.13.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Kelun Group Latest Developments
12.14 B. Braun Medical
12.14.1 Company Information
12.14.2 Colloids (Blood Plasma) Product Offered
12.14.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 B. Braun Medical Latest Developments
12.15 Axa parenterals
12.15.1 Company Information
12.15.2 Colloids (Blood Plasma) Product Offered
12.15.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Axa parenterals Latest Developments
12.16 HOSPIRA
12.16.1 Company Information
12.16.2 Colloids (Blood Plasma) Product Offered
12.16.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 HOSPIRA Latest Developments
12.17 Minsheng Pharma
12.17.1 Company Information
12.17.2 Colloids (Blood Plasma) Product Offered
12.17.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Minsheng Pharma Latest Developments
12.18 Fresenius Kabi(China)
12.18.1 Company Information
12.18.2 Colloids (Blood Plasma) Product Offered
12.18.3 Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Fresenius Kabi(China) Latest Developments
12.19 Fresenius Kabi
12.19.1 Company Information
12.19.2 Colloids (Blood Plasma) Product Offered
12.19.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Fresenius Kabi Latest Developments
12.20 Shandong Hualu Pharmaceutical
12.20.1 Company Information
12.20.2 Colloids (Blood Plasma) Product Offered
12.20.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Shandong Hualu Pharmaceutical Latest Developments
12.21 Kanglepharm
12.21.1 Company Information
12.21.2 Colloids (Blood Plasma) Product Offered
12.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Kanglepharm Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Colloids (Blood Plasma) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Player
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
